Tafadzwa Chimbetete
University Of Cape Town
Cape Town, WC, South Africa
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cutaneous and histopathological features of drug reaction with eosinophila and systemic symptoms differ by HIV status in an HIV-endemic setting.
Journal: JAAD international
Published: May 07, 2026
Genetic polymorphisms and adverse reactions to antituberculosis therapy.
Journal: Pharmacogenomics
Published: June 20, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCAR.
Journal: medRxiv : the preprint server for health sciences
Published: June 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions.
Journal: The journal of allergy and clinical immunology. In practice
Published: May 15, 2025
Integrated renin angiotensin system dysregulation and immune profiles predict COVID-19 disease severity in a South African cohort.
Journal: Scientific reports
Published: October 11, 2024
Utility of IFN-γ Enzyme-Linked Immunospot as Adjunctive Diagnostic for Severe T Cell-Mediated Reactions to Cotrimoxazole in High HIV and Tuberculosis Settings.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 18, 2024
Skin infiltrating T-cell profile of drug reaction with eosinophilia and systemic symptoms (DRESS) reactions among HIV-infected patients.
Journal: Frontiers in medicine
Published: December 07, 2022
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity.
Journal: The Journal of investigative dermatology
Published: March 24, 2022
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting.
Journal: The Journal of investigative dermatology
Published: January 24, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026